🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

39 results for “Indivior” Clear

  1. Intranasal challenge drug

    Indivior Europe Limited

    Heroin Dependence

    phase 3 small molecule completed

    1 trial

  2. RBP-6000

    Indivior Europe Limited

    Opioid Use Disorder

    phase 3 small molecule completed

    4 trials

  3. RBP-7000

    Indivior Europe Limited

    Schizophrenia

    phase 3 small molecule completed

    5 trials

  4. SUBLOCADE

    Indivior Europe Limited

    Opioid Use Disorder

    phase 3 small molecule terminated

    2 trials

  5. SUBOXONE

    Indivior Europe Limited

    Opioid Dependence

    phase 3 small molecule completed

    1 trial

  6. SUBOXONE sublingual film

    Indivior Europe Limited

    Opioid Use Disorder

    phase 3 small molecule completed

    1 trial

  7. Arbaclofen Placarbil

    Indivior Europe Limited

    Alcohol Use Disorder

    phase 2 small molecule completed

    1 trial

  8. Buprenorphine

    Indivior Europe Limited

    Opioid Use Disorder

    phase 2 small molecule completed

    1 trial

  9. Buprenorphine hydrochloride marketed sublingual tablet (Subutex)

    Indivior Europe Limited

    Opioid Dependency

    phase 2 small molecule completed

    1 trial

  10. Buprenorphine soluble film

    Indivior Europe Limited

    Opioid-related Disorders

    phase 2 small molecule completed

    1 trial

  11. Buprenorphine/naloxone Film Strip

    Indivior Europe Limited

    Opioid-Related Disorders

    phase 2 small molecule completed

    1 trial

  12. INDV-2000

    Indivior Europe Limited

    Opioid Use Disorder

    phase 2 small molecule completed

    1 trial

  13. INDV-6001

    Indivior Europe Limited

    Moderate to Severe Opioid Use Disorder

    phase 2 small molecule completed

    1 trial

  14. RBP-6000

    Indivior Europe Limited

    Opioid Related Disorder

    phase 2 small molecule completed

    1 trial

  15. RBP-6300

    Indivior Europe Limited

    Opioid Related Disorder

    phase 2 small molecule completed

    1 trial

  16. RBP-8000 100 mg

    Indivior Europe Limited

    Opioid Dependence

    phase 2 small molecule completed

    1 trial

  17. Risperidone

    Indivior Europe Limited

    Schizophrenia

    phase 2 small molecule completed

    1 trial

  18. XP19986 CR

    Indivior Europe Limited

    GERD

    phase 2 small molecule completed

    1 trial

  19. Arbaclofen Placarbil SR

    Indivior Europe Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  20. Buprenorphine Injectable Solution - Part A

    Indivior Europe Limited

    Healthy

    phase 1 small molecule completed

    1 trial

  21. INDV-2000

    Indivior Europe Limited

    Opioid Dependence

    phase 1 small molecule completed

    1 trial

  22. INDV-2000

    Indivior Europe Limited

    Healthy

    phase 1 small molecule completed

    1 trial

  23. INDV-6200

    Indivior Europe Limited

    Opioid-use Disorder

    phase 1 small molecule completed

    1 trial

  24. [14C]IDV184001AN

    Indivior Europe Limited

    Opioid Use Disorder

    phase 1 small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources